The osmotic laxative magnesium sulphate activates the ileum brake

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 5, 2000, Pages 587-595

  Vu, M K ^b   Nouwens, M A G ^b   Biemond, I ^b   Lamers, C B H W ^b   Masclee, A A M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; LACTULOSE; LAXATIVE; MAGNESIUM SULFATE; PEPTIDE YY;

ADULT; ARTICLE; CASE REPORT; CHOLECYSTOKININ BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DUODENUM MOTILITY; FECES ANALYSIS; FEMALE; GALLBLADDER EMPTYING; HUMAN; ILEUM; INTESTINE ABSORPTION; LIPID ANALYSIS; MALABSORPTION; MALE; MANOMETRY; MEAL; NORMAL HUMAN; PRIORITY JOURNAL; ULTRASOUND;

ADOLESCENT; ADULT; BREATH TESTS; CALCIUM CHANNEL BLOCKERS; FASTING; FECES; FEMALE; GALLBLADDER; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; HUMANS; HYDROGEN; ILEUM; MAGNESIUM SULFATE; MALE;

EID: 0034095266     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00746.x     Document Type: Article

References (24)

1. 1 Welch I, Cunningham KM, Read NW. Regulation of gastric emptying by ileal nutrients in humans. Gastroenterology 1988; 94: 401-4.
2. 2 Lin HC, Zhao XT, Wang L. Intestinal transit is more potently inhibited by fat in the distal (ileal brake) than in the proximal (jejunal brake) gut. Dig Dis Sci 1997; 42: 19-25.
3. 3 Layer P, Peschel S, Schlesinger T, Goebell H. Human pancreatic secretion and intestinal motility: effects of ileal nutrient perfusion. Am J Physiol 1990; 258: G196-201.
4. 4 Lin HC, Zhao XT, Wang L, Wong H. Fat-induced ileal brake in the dog depends on peptide YY. Gastroenterology 1996; 110: 1491-5.
5. 5 Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985; 89: 1070-7.
6. 6 Spiller RC, et al. Further characteristics of the 'ileal brake' reflex in man. Effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. Gut 1988; 29: 1042-51.
7. 7 Adrian TE, Savage AP, Bacarese-Hamilton AJ, Wolfe K, Besterman HS, Bloom SR. Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology 1986; 90: 379-84.
8. 8 Adrian TE, Long RG, Fuessl HS, Bloom SR. Plasma peptide YY (PYY) in dumping syndrome. Dig Dis Sci 1985; 30: 1145-8.
9. 9 Holgate AM, Read NW. Relationship between small bowel transit time and absorption of a solid meal. Influence of metoclopramide, magnesium sulfate, and lactulose. Dig Dis Sci 1983; 28: 812-9.
10. 10 Hampton SM, Morgan LM, Lawrence N, et al. Postprandial hormone and metabolic responses in simulated shift work. J Endocrinol 1996; 151: 259-67.
11. 2) measurements. J Lab Clin Med 1975; 85: 546-55.
12. 12 Everson GT, Braverman DZ, Johnson ML, Kern F Jr. A critical evaluation of real-time ultrasonography for the study of gallbladder Volume and contraction. Gastroenterology 1980; 79: 40-6.
13. 13 Hopman WPM, Brouwer WFM, Rosenbusch G, Jansen JBMJ, Lamers CBHW. A computerized method for rapid quantification of gallbladder volume from real-time sonograms. Radiology 1985; 154: 236-7.
14. 14 Jansen JBMJ, Lamers CBHW. Radioimmunoassay of cholecystokinin in human tissue and plasma. Clin Chim Acta 1983; 131: 305-16.
15. 15 Kellow JE, Borody TJ, Phillips SF, Tucker RL, Haddad AC. Human interdigestive motility: variations in patterns from esophagus to colon. Gastroenterology 1986; 91: 386-95.
16. 16 Izzo AA, Gaginella TS, Capasso F. The osmotic and intrinsic mechanisms of the pharmacological laxative action of oral high doses of magnesium sulphate. Importance of the release of digestive polypeptides and nitric oxide. Magnesium Res 1996; 9: 133-8.
17. 17 Inoue K, Wiener I, Fagan CJ, Watson LC, Thompson JC. Correlation between gallbladder size and release of cholecystokinin after oral magnesium sulfate in man. Ann Surg 1983; 197: 412-5.
18. 18 Izzo AA, Gaginella TS, Mascolo N, Capasso F. Nitric oxide as a mediator of the laxative action of magnesium sulphate. Br J Pharmacol 1994; 113: 228-32.
19. 19 Rodriguez-Membrilla A, Vergara P. Endogenous CCK disrupts the MMC pattern via capsaicin-sensitive vagal afferent fibers in the rat. Am J Physiol 1997; 272: G100-5.
20. 20 Russo A, Fraser R, Adachi K, Horowitz M, Boeckxstaens G. Evidence that nitric oxide mechanisms regulate small intestinal motility in humans. Gut 1999; 44: 72-6. (GENERIC).
21. 21 Stewart JJ, Gaginella TS, Olsen WA, Bass P. Inhibitory actions of laxatives on motility and water and electrolyte transport in the gastrointestinal tract. J Pharmacol Exp Ther 1975; 192: 458-67.
22. 22 Vu MK, Vecht J, Lamers CBHW, Biemond I, Masclee AAM. Activation of 'ileal brake' hormones in dumping syndrome. Gastroenterology 1999; 116: A653(Abstract).
23. 23 Malagelada JR, Holtermuller KM, McCall JT, Go VLW. Pancreatic, gallbladder, and intestinal responses to intraluminal magnesium salts in man. Dig Dis Sci 1978; 23: 481-5.
24. 24 Conter RL, Roslyn JJ, Taylor IL. Effects of peptide YY on gallbladder motility. Am J Physiol 1987; 252: G736-41.